Half of multiple sclerosis patients have significant headaches – often migraine
The publication:
May, 2009
Headache and multiple sclerosis: clinical and therapeutic correlations
Summary of the abstract
Headache is not generally considered as a symptom of multiple sclerosis (MS), but several studies have showed that it is more frequent (about 50%) in MS patients than in controls or general population.
Headache may occur at onset and during the course of the disease. Tension-type headache and migraine without aura are the most commonly reported primary headaches; occipital neuralgia or cluster-like attacks have also been described, the location of demyelinating lesions (cervical or brain stem) could be strategic in these cases.
Furthermore, disease-modifying therapies, such as interferons, may cause or exacerbate headache. These data suggest that MS patients have an increased risk of headache. Preventive therapies may be evaluated in selected patients during chronic treatments to ameliorate compliance.
Related posts:
- Parthenolide (feverfew) for migraine and multiple sclerosis Parthenolide, though previously shown to inhibit NF-kB, was shown in...
- Lack of remission in Sjogren’s syndrome and some forms of multiple sclerosis Unlike most other auto-immune disease, those with Sjogren's do not...
- Incidence of pain and fatigue in multiple sclerosis Approximately half of those with multiple sclerosis (48%) are reported...
- A plant derived product shows promise in the treatment of multiple sclerosis Triptolide, the presumed active component of T. wilfordii, is known...
- Fumaric acid inhibits NF-kappaB, may treat multiple sclerosis Fumaric acid is widely used in Germany (where it is...
